XERIS PHARMACEUTICALS INC Shareholders' Equity
XERIS PHARMACEUTICALS INC had Shareholders' Equity of $19.89 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2021-08-05
- 2021-06-30: Stockholders' Equity Attributable to Parent $19.89M.
- 2021-03-31: Stockholders' Equity Attributable to Parent $44.39M.
- 2020-12-31: Stockholders' Equity Attributable to Parent $33.76M.
- 2020-09-30: Stockholders' Equity Attributable to Parent $14.34M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2021-06-30 | $19.89M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $44.39M 10-Q · filed 2021-08-05 | |
| 2020-12-31 | $33.76M 10-Q · filed 2021-08-05 | |
| 2020-09-30 | $14.34M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $24.38M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $27.07M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $14.44M 10-Q · filed 2021-08-05 | |
| 2019-09-30 | $43.66M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $74.79M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $107.10M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $75.41M 10-K · filed 2021-03-09 | |
| 2018-09-30 | $95.12M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $109.34M 10-Q · filed 2019-11-07 | $109.34M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$69.44M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | -$57.83M 10-K · filed 2020-03-12 | |
| 2016-12-31 | -$31.93M 10-K · filed 2019-03-06 |